logo
Nigerian student happy to find himself, excellent education at MSU Texas

Nigerian student happy to find himself, excellent education at MSU Texas

Yahoo06-03-2025

When Samuel Olatunde first dreamed of coming to America to attend college, he thought basketball would be a part of it.
Duke University came to mind. But Olatunde realized after some time that he was good in basketball in his area, but it wouldn't be his future occupation. He still wanted to come to the United States and found Midwestern State University and Wichita Falls.
'My dad's plan was always to send me abroad to study. He wanted me to go to the UK, but I wanted to go to the U.S.,' Olutunde said. 'I had heard of Texas but not Wichita Falls.'
Starting college in 2020 as the world was experiencing COVID-19, it was the online presence of MSU Texas that gained his attention. But he was excited to come to campus to continue his educational journey, and he earned his bachelor of science from McCoy College of Science, Mathematics and Engineering in December 2024. And he stayed here for graduate school.
He initially didn't want many friends and admitted he wasn't the best at socializing.
'That helped me academically. I became friends with my teachers, and they were supportive,' he said.
He finished with a double major in computer science and mathematics and embraced his chances to do research. His message to others would be to try research.
'You never know until you do it, and you might enjoy it," he said.
After grad school at MSU Texas, he hopes to land a job that involves research.
'It's amazing here at MSU,' Olatunde said. 'It was a beautiful journey. One of the best things for me was it was a smaller school and I had access to (faculty). The support you get here is great. I had a lot of ups and downs and went through a lot of growth. I continued to grow in school and socially.'
His favorite professors included associate professors of computer science Eduard Colmenares-Diaz and Terry Griffin, who was Samuel's adviser and got him started in research, and Marcos Lopez, associate professor of mathematics.
His first MSU experience was an online class from Tiffany Zeigler, and he learned much about the rules for writing papers.
'I slowly picked it up. I had a very terrible relationship with writing (as a youth), but I've understood I can be really good at it. It takes a lot mentally, and I tend to spend a whole lot of time writing," Olatunde said.
Graduation in December was a milestone for him. His parents — dad Sayo and mother Bukola — came to celebrate with him.
He said they always had high goals for him. It was quite a journey, but he showed that belief in him was not misplaced. He just wasn't destined to be an NBA star.
'They would always help and support me, and here my confidence has grown socially and academically. I'm more outspoken and not afraid. (MSU) has helped me grow holistically in every aspect of my life,' Olutunde said.
More: MSU schedules health fair
More: Wichita Falls restaurant inspections: How did they do Feb. 12-24?
This article originally appeared on Wichita Falls Times Record News: Nigerian student happy to find himself, excellent education at MSU Texas

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A quarter of the world's population are adolescents: major report sets out health and wellbeing trends
A quarter of the world's population are adolescents: major report sets out health and wellbeing trends

Yahoo

time2 hours ago

  • Yahoo

A quarter of the world's population are adolescents: major report sets out health and wellbeing trends

The Lancet has released its second global commission report on Adolescent Health and Wellbeing. Adolescents are defined as 10- to 24-year-olds. The report builds on the first one, done in 2016. The latest report presents substantial original research that supports actions it recommends to be taken across sectors as well as at global, regional, country and local level. The co-chairs of the commission, Sarah Baird, Alex Ezeh and Russell Viner, together with the youth commissioners lead, Shakira Choonara, give a guide to the report's findings. The report noted significant improvements in some aspects of adolescent health and wellbeing since the 2016 report. These include reductions in: communicable, maternal and nutritional diseases, particularly among female adolescents the burden of disease from injuries substance use, specifically tobacco and alcohol teenage pregnancy. It also found that there had been an increase in age at first marriage and in education, especially for young women. Despite this progress, adolescent health and wellbeing is said to be at a tipping point. Continued progress is being undermined by rapidly escalating rates of non-communicable diseases and mental disorders, accompanied by threats from compounding and intersecting megatrends. These include climate change and environmental degradation, the growing power of commercial influences on health, rising conflict and displacement, rapid urbanisation, and the aftermath of the COVID-19 pandemic. These megatrends are outpacing responses from national governments and the international community. Born between 2000 and 2014, this is the first cohort of humans who will live their entire life in a time when the average annual global temperature has consistently been 0.5°C or higher above pre-industrial levels. At roughly 2 billion adolescents, they are the largest cohort of adolescents in the history of humanity. And this number will not be surpassed as populations age and fertility rates fall in even the poorest countries. They are the first generation of global digital natives. They live in a world of immense resources and opportunities, with unprecedented connectedness made possible by the rapid expansion of digital technologies. This is true even in the hardest-to-reach places. Growing participation in secondary and tertiary education is equipping adolescents of all genders with new economic opportunities and providing pathways out of poverty. These opportunities, however, are not being realised for most adolescents. Increasing numbers continue to grow up in settings with limited opportunities. In addition, investments in adolescent health and wellbeing continue to lag relative to their population share or their share of the global burden of disease. Investments in adolescents accounted for only 2.4% of the total development assistance for health in 2016-2021. This was despite the fact that adolescents accounted for 25.2% of the global population in that period and 9.1% of the total burden of disease. We use development assistance as a measure because, while governments also invest in adolescents, it's difficult to account for how much this is. For example, when a government supports a health facility, it serves the entire population. Yet, the report provides evidence to show that the return on investments in adolescent health and wellbeing is highly cost-effective and at par with investments in children. The report recognises the special place of Africa in the global future of adolescents. It notes that, by the end of this century, nearly half of all adolescents will live in Africa. Currently, adolescents in Africa experience higher burdens of communicable, maternal and nutritional diseases, at more than double the global average for both male and female adolescents. They also have a higher prevalence of anaemia, adolescent childbearing, early marriage and HIV infection. They are much less likely to complete 12 years of schooling and more likely to not be in education, employment, or training. Female adolescents in sub-Saharan Africa have the highest adolescent fertility rate at 99.4 births per 1,000 female adolescents aged 15-19 (the global average is 41.8). They have also experienced the slowest decline between 2016 and 2022. Globally, there was progress in reducing child marriage between 2016 and 2022. But in eight countries in 2022, at least one in three female adolescents aged 15–19 years was married. All but one of these eight countries were in sub-Saharan Africa. Niger (50.2%) and Mali (40.6%) had the highest proportion of married female adolescents. The practice of child marriage is declining in south Asia and becoming more concentrated in sub-Saharan Africa. As the report notes: it continues because of cultural norms, fuelled by economic hardships, insurgency, conflict, ambiguous legal provisions, and lack of political will to enforce legal provisions. Beyond adolescent sexual and reproductive health concerns in sub-Saharan Africa, obesity is increasing fastest in the region. This illustrates the vulnerability of adolescents to the power of commercial interests. Since 1990, obesity and overweight has increased by 89% in prevalence among adolescents aged 15–19 years in sub-Saharan Africa. This is the largest regional increase. The absence of data on adolescents is a problem. Adolescents in sub-Saharan Africa are absent in many data systems. For example, data on adolescent mental health in sub-Saharan Africa is virtually absent. Stronger data systems are needed to understand and track progress on the complex set of determinants of adolescent health and wellbeing. Another area of concern is the massive inequities within countries, often gendered or by geography. While female adolescents in Kenya are experiencing substantial declines in the burden of HIV and sexually transmitted infections, adolescent males are experiencing increasing burdens. In South Africa, years of healthy life lost to maternal disorders show more than 10-fold differences between the Western Cape and North West provinces. Where there's been strong political leadership, remarkable changes have been seen. Take the case of Benin Republic. The adolescent fertility rate in the country declined from 26% in 1996 to 20% in 2018 and child marriage from 39% to 31% over the same period. Strong political leadership has also led to substantial reductions in female genital mutilation or cutting. This fell from 12% of girls in Benin in 2001 to 2% in 2011–12 among 15–19-year-old girls in Benin Republic. Political leadership also facilitated the expansion, by the national parliament in 2021, of the grounds under which women, girls, and their families could access safe and legal abortion. But for every country that takes positive steps to protect the health and wellbeing of adolescents, several others regress. The last decade has witnessed regression in several countries. In 2024, The Gambia attempted to repeal a 2015 law criminalising all acts of female genital mutilation or cutting. In 2022, Nigeria's federal government ordered the removal of sex education from the basic education curriculum. The report calls for a multisectoral approach across multiple national ministries and agencies, including the office of the head of state, and within the UN system. Coordination and accountability mechanisms for adolescent health and wellbeing also need to be strengthened. Laws and policies are needed to protect the health and rights of adolescents, reduce the impact of the commercial determinants of health, and promote healthy use of digital and social media spaces and platforms. Strong political leadership at local, national, and global levels is essential. The report also calls for prioritised investments, the creation of enabling environments to transform adolescent health and wellbeing, and the development of innovative approaches to address complex and emerging health threats. It calls for meaningful engagement of adolescents in policy, research, interventions and accountability mechanisms that affect them. Without these concerted actions, we risk failing our young people and losing out on the investments being made in childhood at this second critical period in their development. The current adverse international aid climate is particularly affecting adolescents as much development assistance relates to gender and sexual and reproductive health. Concerted action in addressing adolescent health and wellbeing is an urgent imperative for sub-Saharan Africa. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Alex Ezeh, Drexel University; Russell Viner, UCL, and Sarah Baird, George Washington University Read more: Canada must take action to prevent climate-related migration We design cities and buildings for earthquakes and floods — we need to do the same for wildfires Eating wild meat carries serious health risks – why it still happens along the Kenya-Tanzania border Alex Ezeh is a fellow at the Stellenbosch Institute for Advanced Study (Stias). Russell Viner and Sarah Baird do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

"We dissent": NIH scientists sign declaration against Trump's research cuts
"We dissent": NIH scientists sign declaration against Trump's research cuts

Yahoo

time2 hours ago

  • Yahoo

"We dissent": NIH scientists sign declaration against Trump's research cuts

National Institute of Health scientists signed a declaration decrying the cuts to healthcare and medical research by the Trump administration on Monday. Ninety-two scientists added their names to a letter, the Bethesda Declaration, which calls out the Trump administration's handling of the NIH and the cutting of more than 2,100 research grants and contracts, totaling more than $12 billion in federal funding. The letter, named for NIH's headquarters in Maryland, expresses the scientists' "dissent" and outrage over Trump administration policies "that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe." The declaration points to canceled studies, including work on the long-lasting effects of COVID-19 and climate change-related health impacts. "Ending a $5 million research study when it is 80% complete does not save $1 million," the declaration states, "it wastes $4 million." Along with the 92 named signatories, more than 250 scientists at the NIH signed the declaration anonymously. "We include anonymous signers and speak for countless others at NIH," the letter concluded, "who share our concerns but who — due to a culture of fear and suppression created by this Administration — chose not to sign their names for fear of retaliation."The declaration was delivered to NIH Director Jay Bhattacharya on Monday. Bhattacharya said the declaration "has some fundamental misconceptions about the policy directions the NIH has taken in recent months." "Nevertheless," he continued, "respectful dissent in science is productive. We all want the NIH to succeed."

GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients

Yahoo

time2 hours ago

  • Yahoo

GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients

ATLANTA, GA - June 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against infectious diseases and solid tumors, today announced that clinical data for its next-generation COVID-19 multi-antigen vaccine candidate, GEO-CM04S1, will be presented at the European Hematology Association (EHA) 2025 Hybrid Congress, taking place June 1215, 2025, in Milan, Italy and online. Alexey V. Danilov, M.D., Ph.D., Associate Director of the Toni Stephenson Lymphoma Center and Professor in the Department of Hematology and Hematopoietic Cell Transplantation at the City of Hope Comprehensive Cancer Center in Duarte, California, will present a poster titled: "MVA-Based GEO-CM04S1 Vaccine Results in Improved Cellular Immune Response in Patients with Chronic Lymphocytic Leukemia (CLL) Compared with mRNA-Based Vaccine: Initial Results of a Phase II Randomized Study". The poster will be featured on Saturday, June 14, 2025, from 18:30 to 18:30 CEST in the Poster Hall, as part of the session on Infections in Hematology (including supportive care/therapy). The presentation will highlight initial results from a Phase II randomized clinical trial highlighting the superior cellular immune response of GEO-CM04S1 compared to an authorized mRNA-based COVID-19 vaccine in CLL patients - a population known to exhibit suboptimal protective responses to COVID-19 and other vaccines due to immune dysfunction. The findings will underscore the differentiated mechanism and clinical potential of the GeoVax MVA multi-antigen platform, particularly in immunocompromised individuals. "GEO-CM04S1 continues to show promise as a vaccine option for populations with suboptimal protection from existing COVID-19 vaccines," said Kelly T. McKee, Jr., M.D., Chief Medical Officer of GeoVax. "We are proud to have these important data showcased at EHA2025, reflecting the real-world needs of patients with hematologic malignancies." About GEO-CM04S1 GEO-CM04S1 is a multi-antigen COVID-19 vaccine designed using a synthetic Modified Vaccinia Ankara (MVA) vector platform. The vaccine expresses both spike (S) and nucleocapsid (N) antigens of SARS-CoV-2, aiming to provide broader and more durable immune protection. It is currently being evaluated in Phase 2 clinical trials in both immunocompromised and healthy adults. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. The Company is also developing GEO-MVA, a vaccine targeting Mpox and smallpox. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: Company Contact:info@ Investor Relations Contact:geovax@ Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store